The role of chemotherapy in the treatment of esophageal cancer.
Forastiere
Arlene
A
Johns Hopkins University School of Medicine, MD, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D019468:Disease Management; D016503:Drug Delivery Systems; D066246:ErbB Receptors / Q000032:analysis / Q000037:antagonists & inhibitors; D004938:Esophageal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D016629:Esophagectomy; D018773:Genes, erbB-1; D006801:Humans; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011379:Prognosis; D011859:Radiography; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D015996:Survival Rate; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; C512478:EGFR protein, human; D066246:ErbB Receptors